IL7 and neoplasm: To further stress the in vitro system, we set up a second tumor re-challenge assay in which CAR T cells were expanded for 10 days in the presence of IL-7 and IL15, co-cultured with Namalwa cells at E:T ratio of 1:1 and challenged every day (Figure 5A).